Fast Five Quiz: Squamous Cell Non-Small Cell Lung Cancer

Maurie Markman, MD


September 15, 2022

Lung cancer continues to be the leading cause of cancer-related deaths worldwide. Non–small cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancers and is divided histologically into adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. In the United States, Canada, and many European countries, squamous cell carcinoma is the second most common histologic subtype of lung cancer; in other countries, such as Spain and the Netherlands, it remains the most common. If identified early, squamous cell NSCLC has a favorable prognosis. Unfortunately, most patients have advanced disease at the time of diagnosis, which is associated with a poor prognosis. Identifying individuals at risk for lung cancer can facilitate an early diagnosis and allow for improved treatment outcomes.

How much do you know about squamous cell NSCLC? Test your knowledge with this quick quiz.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.